Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 26, 2021
Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma.
Journal: Cancer immunology, immunotherapy : CII
Published: July 05, 2016
The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up.
Journal: Gynecologic oncology reports
Published: May 24, 2016
HIV Infection Leads to Redistribution of Leaky Claudin-2 in the Intestine of Humanized SCID IL-2R(-/-) Hu-PBMC Mice.
Journal: AIDS research and human retroviruses
Published: April 09, 2015
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.
Journal: Journal for immunotherapy of cancer
Published: March 09, 2015
HIV infection accelerates gastrointestinal tumor outgrowth in NSG-HuPBL mice.
Journal: AIDS research and human retroviruses
Published: March 06, 2014
Antigenic peptide nanofibers elicit adjuvant-free CD8⁺ T cell responses.
Journal: Vaccine
Published: May 09, 2013
Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
Journal: Science translational medicine
Published: March 01, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026